346 related articles for article (PubMed ID: 25799995)
21. Tyrosine kinase fusion genes in pediatric BCR-ABL1-like acute lymphoblastic leukemia.
Boer JM; Steeghs EM; Marchante JR; Boeree A; Beaudoin JJ; Beverloo HB; Kuiper RP; Escherich G; van der Velden VH; van der Schoot CE; de Groot-Kruseman HA; Pieters R; den Boer ML
Oncotarget; 2017 Jan; 8(3):4618-4628. PubMed ID: 27894077
[TBL] [Abstract][Full Text] [Related]
22. B-cell receptor signalling and its crosstalk with other pathways in normal and malignant cells.
Seda V; Mraz M
Eur J Haematol; 2015 Mar; 94(3):193-205. PubMed ID: 25080849
[TBL] [Abstract][Full Text] [Related]
23. Synergism between IL7R and CXCR4 drives BCR-ABL induced transformation in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Abdelrasoul H; Vadakumchery A; Werner M; Lenk L; Khadour A; Young M; El Ayoubi O; Vogiatzi F; Krämer M; Schmid V; Chen Z; Yousafzai Y; Cario G; Schrappe M; Müschen M; Halsey C; Mulaw MA; Schewe DM; Hobeika E; Alsadeq A; Jumaa H
Nat Commun; 2020 Jun; 11(1):3194. PubMed ID: 32581241
[TBL] [Abstract][Full Text] [Related]
24. Activation of the Syk tyrosine kinase is insufficient for downstream signal transduction in B lymphocytes.
Hsueh RC; Hammill AM; Lee JA; Uhr JW; Scheuermann RH
BMC Immunol; 2002 Dec; 3():16. PubMed ID: 12470302
[TBL] [Abstract][Full Text] [Related]
25. Deregulated Syk inhibits differentiation and induces growth factor-independent proliferation of pre-B cells.
Wossning T; Herzog S; Köhler F; Meixlsperger S; Kulathu Y; Mittler G; Abe A; Fuchs U; Borkhardt A; Jumaa H
J Exp Med; 2006 Dec; 203(13):2829-40. PubMed ID: 17130299
[TBL] [Abstract][Full Text] [Related]
26. A balance of Bruton's tyrosine kinase and SHIP activation regulates B cell receptor cluster formation by controlling actin remodeling.
Liu C; Miller H; Hui KL; Grooman B; Bolland S; Upadhyaya A; Song W
J Immunol; 2011 Jul; 187(1):230-9. PubMed ID: 21622861
[TBL] [Abstract][Full Text] [Related]
27. RAG enhances BCR-ABL1-positive leukemic cell growth through its endonuclease activity in vitro and in vivo.
Yuan M; Wang Y; Qin M; Zhao X; Chen X; Li D; Miao Y; Otieno Odhiambo W; Liu H; Ma Y; Ji Y
Cancer Sci; 2021 Jul; 112(7):2679-2691. PubMed ID: 33949040
[TBL] [Abstract][Full Text] [Related]
28. Development of resistance to dasatinib in Bcr/Abl-positive acute lymphoblastic leukemia.
Fei F; Stoddart S; Müschen M; Kim YM; Groffen J; Heisterkamp N
Leukemia; 2010 Apr; 24(4):813-20. PubMed ID: 20111071
[TBL] [Abstract][Full Text] [Related]
29. Reconstitution of B cell antigen receptor-induced signaling events in a nonlymphoid cell line by expressing the Syk protein-tyrosine kinase.
Richards JD; Gold MR; Hourihane SL; DeFranco AL; Matsuuchi L
J Biol Chem; 1996 Mar; 271(11):6458-66. PubMed ID: 8626447
[TBL] [Abstract][Full Text] [Related]
30. B cell antigen receptor-induced activation of Akt promotes B cell survival and is dependent on Syk kinase.
Pogue SL; Kurosaki T; Bolen J; Herbst R
J Immunol; 2000 Aug; 165(3):1300-6. PubMed ID: 10903730
[TBL] [Abstract][Full Text] [Related]
31. Autoimmunity checkpoints as therapeutic targets in B cell malignancies.
Müschen M
Nat Rev Cancer; 2018 Feb; 18(2):103-116. PubMed ID: 29302068
[TBL] [Abstract][Full Text] [Related]
32. Paired immunoglobulin-like receptor B (PIR-B) inhibits BCR-induced activation of Syk and Btk by SHP-1.
Maeda A; Scharenberg AM; Tsukada S; Bolen JB; Kinet JP; Kurosaki T
Oncogene; 1999 Apr; 18(14):2291-7. PubMed ID: 10327049
[TBL] [Abstract][Full Text] [Related]
33. Monovalent and multivalent ligation of the B cell receptor exhibit differential dependence upon Syk and Src family kinases.
Mukherjee S; Zhu J; Zikherman J; Parameswaran R; Kadlecek TA; Wang Q; Au-Yeung B; Ploegh H; Kuriyan J; Das J; Weiss A
Sci Signal; 2013 Jan; 6(256):ra1. PubMed ID: 23281368
[TBL] [Abstract][Full Text] [Related]
34. CD22 associates with protein tyrosine phosphatase 1C, Syk, and phospholipase C-gamma(1) upon B cell activation.
Law CL; Sidorenko SP; Chandran KA; Zhao Z; Shen SH; Fischer EH; Clark EA
J Exp Med; 1996 Feb; 183(2):547-60. PubMed ID: 8627166
[TBL] [Abstract][Full Text] [Related]
35. A mouse Fcgamma-Fcepsilon protein that inhibits mast cells through activation of FcgammaRIIB, SH2 domain-containing inositol phosphatase 1, and SH2 domain-containing protein tyrosine phosphatases.
Mertsching E; Bafetti L; Hess H; Perper S; Giza K; Allen LC; Negrou E; Hathaway K; Hopp J; Chung J; Perret D; Shields M; Saxon A; Kehry MR
J Allergy Clin Immunol; 2008 Feb; 121(2):441-447.e5. PubMed ID: 17949802
[TBL] [Abstract][Full Text] [Related]
36. The dynamics of protein kinase B regulation during B cell antigen receptor engagement.
Astoul E; Watton S; Cantrell D
J Cell Biol; 1999 Jun; 145(7):1511-20. PubMed ID: 10385529
[TBL] [Abstract][Full Text] [Related]
37. Enhanced Tyrosine Phosphatase Activity Underlies Dysregulated B Cell Receptor Signaling and Promotes Survival of Human Lupus B Cells.
Fleischer SJ; Daridon C; Fleischer V; Lipsky PE; Dörner T
Arthritis Rheumatol; 2016 May; 68(5):1210-21. PubMed ID: 26713408
[TBL] [Abstract][Full Text] [Related]
38. The BAFF receptor transduces survival signals by co-opting the B cell receptor signaling pathway.
Schweighoffer E; Vanes L; Nys J; Cantrell D; McCleary S; Smithers N; Tybulewicz VL
Immunity; 2013 Mar; 38(3):475-88. PubMed ID: 23453634
[TBL] [Abstract][Full Text] [Related]
39. PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine.
Okazaki T; Maeda A; Nishimura H; Kurosaki T; Honjo T
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13866-71. PubMed ID: 11698646
[TBL] [Abstract][Full Text] [Related]
40. Src homology 2 domain-containing protein-tyrosine phosphatases, SHP-1 and SHP-2, are required for platelet endothelial cell adhesion molecule-1/CD31-mediated inhibitory signaling.
Henshall TL; Jones KL; Wilkinson R; Jackson DE
J Immunol; 2001 Mar; 166(5):3098-106. PubMed ID: 11207261
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]